Alfa Wassermann competitive analysis

Latest publications and patents of Alfa Wassermann New

Explore the latest publications and patents granted to Alfa Wassermann, showcasing their recent innovations and technological advancements.

Last updated on: Sep 22, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Alfa Wassermann

Nov 1, 2017Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal DiseaseRevoked
Jun 7, 2017Sulodexide For Use In The Treatment Of Pathologies Wherein Metalloproteinases Are InvolvedRevoked
Apr 19, 2017Use Of Polyols To Obtain Stable Polymorphous Forms Of RifaximinGranted And Under Opposition

Explore Alfa Wassermann's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Nov 1, 2017Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease1
Jun 7, 2017Sulodexide For Use In The Treatment Of Pathologies Wherein Metalloproteinases Are Involved2
Apr 19, 2017Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaximin3

Latest PTAB cases involving Alfa Wassermann

Discover the latest PTAB cases involving Alfa Wassermann, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Alfa Wassermann with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ALFA WASSERMANN - 6 - - Non-Active
BOTTI & FERRARI13 - - - Highly Aggressive
GENERICS UK211 - - - Highly Aggressive
SANDOZ1141519 - Highly Aggressive